TNF and infection: However, several studies have shown that the rates of overall infections and serious infections do not significantly differ between combination therapy with TNF inhibitors and MTX and MTX monotherapy for RA [6, 11, 12, 24], whereas other studies have shown that the rate of serious infections is significantly higher in the combination therapy than MTX therapy [7, 8, 10].